Lantheus Holdings (LNTH) Shares Outstanding (Diluted Average) (2015 - 2025)

Lantheus Holdings (LNTH) reported Shares Outstanding (Diluted Average) of $71.5 million for Q1 2025, up 1.95% year-over-year from $70.1 million in Q1 2024, and little changed quarter-over-quarter from $71.7 million in Q4 2024.

Lantheus Holdings (LNTH) Shares Outstanding (Diluted Average) (2015 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has 11 years of Shares Outstanding (Diluted Average) data on file, last reported at $71.5 million in Q1 2025.

  • Shares Outstanding (Diluted Average) for Q1 2025 came in at $71.5 million, up 1.95% year-over-year; the trailing twelve-month figure through Mar 2025 was $71.5 million (up 1.95% YoY), and the FY2024 annual result was $71.7 million, up 2.01% from the prior year.
  • Shares Outstanding (Diluted Average) was little changed at $71.5 million in Q1 2025 per LNTH's latest filing, from $71.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $73.1 million in Q3 2024 and troughed at $67.5 million in Q4 2021.
  • A 5-year average of $69.8 million and a median of $70.1 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Diluted Average) surged 68.85% in 2021, then dropped 3.29% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $67.5 million in 2021, then climbed by 4.72% to $70.7 million in 2022, then decreased by 0.61% to $70.2 million in 2023, then rose by 2.01% to $71.7 million in 2024, then declined by 0.27% to $71.5 million in 2025.
  • Business Quant data shows LNTH's Shares Outstanding (Diluted Average) at $71.5 million in Q1 2025, $71.7 million in Q4 2024, and $73.1 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 101.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 71.46 Mn
Dec 31, 2024 71.65 Mn
Sep 30, 2024 73.07 Mn
Jun 30, 2024 70.36 Mn
Mar 31, 2024 70.10 Mn
Dec 31, 2023 70.24 Mn
Sep 30, 2023 70.05 Mn
Jun 30, 2023 69.96 Mn
Mar 31, 2023 67.75 Mn
Dec 31, 2022 70.67 Mn
Sep 30, 2022 70.67 Mn
Jun 30, 2022 70.80 Mn
Mar 31, 2022 70.05 Mn
Dec 31, 2021 67.49 Mn
Sep 30, 2021 67.62 Mn
Jun 30, 2021 67.51 Mn
Mar 31, 2021 67.71 Mn
Dec 31, 2020 54.13 Mn
Sep 30, 2020 49.86 Mn
Jun 30, 2020 43.14 Mn